Abiopharma

GeneDx to Present at the J.P. Morgan 2026 Healthcare Conference

IM Cannabis Explores U.S. Market Entry Following President Trumps Executive Order on Increasing Medical Marijuana and Cannabidiol Research

XOMA Royalty and Takeda Execute Strategic Royalty Sharing Transaction and Amend Existing Agreement for Mezagitamab

InflaRx Provides Update on Phase 3 Data Analyses for Vilobelimab in Pyoderma Gangrenosum

XOMA Royalty and Takeda Execute Strategic Royalty Sharing Transaction and Amend Existing Agreement for Mezagitamab

Beyond Air® Appoints Dan Moorhead as Chief Financial Officer

NeoGenomics Appoints Diagnostics and Lab Services Industry Veteran John P. “Jack” Kenny to its Board of Directors

Cypherpunk Accelerates Zcash Accumulation; Increases Treasury Holdings to 290,062.67 ZEC

Evogene Announces Appointment of Dr. Olga Nissan as its Vice President of Business Development

EUDA Launches Nationwide Stem Cell Extraction, Cryostorage and Clinical Delivery Platform in China with Shenzhen Inno Immune and Wuhan Kaien Hospital